Gary Mansfield

Gary Mansfield serves as an Advisory Partner.
Mr. Mansfield, Managing Partner of Mansfield, Bronstein, & Stone, LLP has been a member of the Florida Bar since 1995.
He has served as chief executive and president of several public and private companies.
In both 2013 and 2019, Gary was selected as “Most Effective Lawyer” by the Daily Business Review for two complex civil litigation matters, including a class action brought on behalf of more than 12,000 class members, which settled for an amount in excess of $200 million.
Mr. Mansfield was employed in the healthcare industry as the Director of Mergers and Acquisitions for National Medical Health Card Systems, Inc. (NASDAQ:NMHC), a leading pharmacy benefit management company.
Prior to this position, Mr. Mansfield was employed as the President and Chief Operating Officer of NMHC Mail Order, Inc., a specialty pharmaceutical and mail order pharmacy, wholly-owned by NMHC.
Additionally, Gary was a principal in several healthcare ventures including an independent retail pharmacy chain; a pharmacy benefit management company; a managed care pharmacy; and an automated mail order pharmacy business.
Mr. Mansfield has previously held senior management and board positions at several healthcare companies including Best Generics., Inc. (sold to Ivax Corp.
AMEX:IVX); Medical Containment Systems, Inc. (sold to ProxyMed, Inc. NASDAQ:PILL); PlanVista, Inc (NASDAQ:PVST); and US Script sold to Centene Corp.
(NYSE:CNC).
In addition to his direct healthcare experience, Mr. Mansfield was employed as the Director of Healthcare Investment Banking at Capitalink, LLC, where he provided clients with strategic guidance and assistance in implementing mergers and acquisitions.
Thereafter, Mr. Mansfield was an advisory and investment professional at Barnett & Partners, LLC, a New York-based merchant bank dedicated to strategic advisory, wealth management and specialty investment opportunities.